BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1690 related articles for article (PubMed ID: 18565598)

  • 41. What is the natural history of recurrent acute otitis media in infancy?
    Alho OP; Läärä E; Oja H
    J Fam Pract; 1996 Sep; 43(3):258-64. PubMed ID: 8797753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Topical versus oral antibiotics, with or without corticosteroids, in the treatment of tympanostomy tube otorrhea.
    Chee J; Pang KW; Yong JM; Ho RC; Ngo R
    Int J Pediatr Otorhinolaryngol; 2016 Jul; 86():183-8. PubMed ID: 27260604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MRSA and non-MRSA otorrhea in children: a comparative study of clinical course.
    Alexander NS; Kulbersh BD; Heath CH; Desmond RA; Caron E; Woolley AL; Hill JS; Shirley WP; Wiatrak BJ
    Arch Otolaryngol Head Neck Surg; 2011 Dec; 137(12):1223-7. PubMed ID: 22183901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
    Rahman A; Rizwan S; Waycaster C; Wall GM
    Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A trial of treatment for acute otorrhea in children with tympanostomy tubes.
    van Dongen TM; van der Heijden GJ; Venekamp RP; Rovers MM; Schilder AG
    N Engl J Med; 2014 Feb; 370(8):723-33. PubMed ID: 24552319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cochlear implantation in children with otitis media: third stage of a long-term prospective study].
    Luntz M; Khalaila J; Brodsky A; Shpak T
    Harefuah; 2007 Feb; 146(2):106-10, 166. PubMed ID: 17352278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Tympanostomy tube otorrhea: microbiological epidemiology, pathogen susceptibility to local antibiotics and bactericidal power of the rifamycin-olfloxacin combination].
    François M; Mariani-Kurkdjian P; Doit C; Benzekri P; Bingen E; Macé JG
    Ann Otolaryngol Chir Cervicofac; 2001 Oct; 118(5):278-82. PubMed ID: 11845035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical manifestations and risk factors of children receiving triple ventilating tube insertions for treatment of recurrent otitis media with effusion.
    Ahn JH; Yoon TH; Pae KH; Kim TS; Chung JW; Lee KS
    Pediatrics; 2006 Jun; 117(6):e1119-23. PubMed ID: 16702251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural features of tympanostomy tube biofilm formation in ciprofloxacin-resistant Pseudomonas otorrhea.
    Jang CH; Cho YB; Choi CH
    Int J Pediatr Otorhinolaryngol; 2007 Apr; 71(4):591-5. PubMed ID: 17239963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of adenoidectomy and tympanostomy tubes in the treatment of chronic otitis media with effusion.
    Gates GA; Avery CA; Prihoda TJ; Cooper JC
    N Engl J Med; 1987 Dec; 317(23):1444-51. PubMed ID: 3683478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcome analysis of children receiving tympanostomy tubes.
    Franklin JH; Marck PA
    J Otolaryngol; 1998 Oct; 27(5):293-7. PubMed ID: 9800629
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inner ear and facial nerve complications of acute otitis media with focus on bacteriology and virology.
    Hydén D; Akerlind B; Peebo M
    Acta Otolaryngol; 2006 May; 126(5):460-6. PubMed ID: 16698694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of topical ciprofloxacin on postoperative otorrhea after tympanostomy tube insertion.
    Zipfel TE; Wood WE; Street DF; Wulffman J; Tipirneni A; Frey C; Gibson WS
    Am J Otol; 1999 Jul; 20(4):416-20. PubMed ID: 10431879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute otitis media in children with tympanostomy tubes.
    Schmelzle J; Birtwhistle RV; Tan AK
    Can Fam Physician; 2008 Aug; 54(8):1123-7. PubMed ID: 18697973
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interferon-gamma in suppurative otitis media: significance of otorrhoea type and disease outcome.
    Lasisi AO; Olayemi O; Arinola OG; Omilabu SA
    J Laryngol Otol; 2009 Oct; 123(10):1103-7. PubMed ID: 19640314
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hearing thresholds and tympanic membrane sequelae in children managed medically or surgically for otitis media with effusion.
    Stenstrom R; Pless IB; Bernard P
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1151-6. PubMed ID: 16330739
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alternative versus conventional treatment strategy in uncomplicated acute otitis media in children: a prospective, open, controlled parallel-group comparison.
    Wustrow TP;
    Int J Clin Pharmacol Ther; 2004 Feb; 42(2):110-9. PubMed ID: 15180172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors for postoperative otorrhea following tympanostomy tube insertion.
    Giebink GS; Daly K; Buran DJ; Satz M; Ayre T
    Arch Otolaryngol Head Neck Surg; 1992 May; 118(5):491-4. PubMed ID: 1571119
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current bacteriology of chronic otitis media with effusion: high rate of nosocomial infection and decreased antibiotic sensitivity.
    Jung H; Lee SK; Cha SH; Byun JY; Park MS; Yeo SG
    J Infect; 2009 Nov; 59(5):308-16. PubMed ID: 19715725
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Seromucous otitis].
    Tran Ba Huy P; Sauvaget E; Portier F
    Ann Otolaryngol Chir Cervicofac; 2007 Jul; 124(3):120-5. PubMed ID: 17434139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 85.